A new prostate cancer treatment might offer more effective treatment for patients and have fewer side-effects, according to a new report.

portrait of two male scientists and a female scientist standing in a row and smiling

The study was the first to use a new  treatment called as HIFU (high-intensity focused ultrasound) to treat areas of cancer that are just a few millimeters in size, a method that is known as focal therapy.

Focal therapy is similar to the “lumpectomy” operation often used as an alternative to a full mastectomy in breast cancer patients.

A year after treatment none of the 41 men that took part in the trial had incontinence, and only one in 10 of them had poor erections, both of which are common side-effects of conventional prostate cancer treatment. The majority (95%) of participants were also cancer-free one year after their treatment.

Researchers said that “focal therapy of individual prostate cancer lesions, whether multifocal or unifocal, leads to a low rate of genito-urinary side-effects and an encouraging rate of early absence of clinically significant prostate cancer”.

The results of the phase one study, which was funded by the Medical Research Council and carried out by researchers at University College London, have been published in the journal Lancet Oncology.

Dr Hashim Ahmed led the study at University College London Hospitals NHS Foundation Trust and UCL and commented: “Our results are very encouraging. We’re optimistic that men diagnosed with prostate cancer may soon be able to undergo a day case surgical procedure, which can be safely repeated once or twice, to treat their condition with very few side-effects. That could mean a significant improvement in their quality of life.

“This study provides the proof-of-concept we need to develop a much larger trial to look at whether focal therapy is as effective as the current standard treatment in protecting the health of the men treated for prostate cancer in the medium and long term.”

Angeles hospital in Tijuana

Angeles hospital in Tijuana

At Angeles Health we believe in targeted cancer treatment and we have devised a method that targets prostate cancer cells in particular. PROSTACIT goes beyond ultrasound and uses cell technologies so that the body’s natural immune response is jolted into action through cell treatment and thus able to eliminate cancer as it would in its usual health state. To learn more about our program in Mexico and how we deal with prostate cancer please contact us using the form on the right.